Loading...
The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
SIMPLE SUMMARY: Several anti-angiogenic drugs have been approved for cancer treatment, alone or in combination with other anti-tumoral agents. Angiogenesis inhibitors cause drug resistance, metastasis formation, and reduced delivery of chemotherapeutic agents, as a consequence of decrease of tumor v...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8304542/ https://ncbi.nlm.nih.gov/pubmed/34298648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143433 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|